Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention.

Published in:

Breast Cancer Research & Treatment, 2019, v. 173, n. 3, p. 559, doi. 10.1007/s10549-018-4992-7

By:

• Walter, Katherine R.;
• Ford, Marvella E.;
• Gregoski, Mathew J.;
• Kramer, Rita M.;
• Knight, Kendrea D.;
• Spruill, Laura;
• Nogueira, Lourdes M.;
• Krisanits, Bradley A.;
• Phan, Van;
• La Rue, Amanda C.;
• Lilly, Michael B.;
• Ambs, Stefan;
• Chan, King;
• Turner, Tonya F.;
• Varner, Heidi;
• Singh, Shweta;
• Uribarri, Jaime;
• Garrett-Mayer, Elizabeth;
• Armeson, Kent E.;
• Hilton, Ebony J.

Publication type:

Article